The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Abstract
Active multiple sclerosis lesions show inflammatory changes suggestive of a combined attack by autoreactive T and B lymphocytes against brain white matter. These pathogenic immune cells derive from progenitors that are normal, innocuous components of the healthy immune repertoire but become autoaggressive upon pathological activation. The stimuli triggering this autoimmune conversion have been commonly attributed to environmental factors, in particular microbial infection. However, using the relapsing-remitting mouse model of spontaneously developing experimental autoimmune encephalomyelitis, here we show that the commensal gut flora-in the absence of pathogenic agents-is essential in triggering immune processes, leading to a relapsing-remitting autoimmune disease driven by myelin-specific CD4(+) T cells. We show further that recruitment and activation of autoantibody-producing B cells from the endogenous immune repertoire depends on availability of the target autoantigen, myelin oligodendrocyte glycoprotein (MOG), and commensal microbiota. Our observations identify a sequence of events triggering organ-specific autoimmune disease and these processes may offer novel therapeutic targets.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to psoriasis, IL-17 pathway inhibitors (secukinumab and ixekizumab) have been shown to be effective in the treatment of PsA [141, 142].”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [142]
In the citing paper
“in a laboratory model of multiple sclerosis, mice sensitized to the autoantigen, myelin oligodendrocyte glycoprotein, only developed experimental autoimmune encephalitis in the presence of commensal bacteria.45”
From The Gut Microbiome and the Brain (2014) · cites this paper as [45]
Citations
Cites
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Ivanov, I. I., Frutos, R. D. L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B., & Littman, D. R. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.009 · Cited by 1,770
Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.020 · Cited by 1,452
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,036
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694
Goverman, J. M., Woods, A., Larson, L., Weiner, L. P., Hood, L., & Zaller, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90074-z · Cited by 684
Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
Hill, D. A., & Artis, D. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101330 · Cited by 600
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,000
Nemoto, Y., Kanai∥, T., Takahara, M., Oshima, S., Okamoto, R., Tsuchiya, K., Matsumoto, S., & Watanabe, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202930 · Cited by 13
Uhde, A., Herder, V., Khan, M. A., Ciurkiewicz, M., Schaudien, D., Teich, R., Floess, S., Baumgärtner, W., Huehn, J., & Beineke, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161883 · Cited by 13
An introduction to the microbiome and MS
Trott, S., & King, I. L. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737391 · Cited by 13
Commensal regulation of T cell survival through Erdr1
Weis, A. M., Soto, R. A., & Round, J. L. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1441662 · Cited by 13
Metaorganismal choline metabolism shapes olfactory perception
Massey, W. J., Kay, K. E., Jaramillo, T. C., Horak, A. J., Cao, S., Osborn, L. J., Banerjee, R., Mrdjen, M., Hamoudi, M. K., Silver, D. J., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105299 · Cited by 13
Short‐chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset
Schoeps, V. A., Zhou, X., Horton, M. K., Zhu, F., McCauley, K. E., Nasr, Z., Virupakshaiah, A., Gorman, M., Benson, L. A., Weinstock‐Guttman, B., et al. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51944 · Cited by 13
The Role of Gut Microbiota in Neuromyelitis Optica Spectrum Disorder
Yao, S., Yang, X., Cen, L., & Tan, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063179 · Cited by 12
Faecal microbiota transplantation—A clinical view
Mattner, J., Schmidt, F., & Siegmund, B. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.02.003 · Cited by 12
The Autoantigen Repertoire and the Microbial RNP World
Williams, S. G., & Wolin, S. L. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.02.003 · Cited by 12
Angiotensin (1–7) Expressing Probiotic as a Potential Treatment for Dementia
Hernandez, A. R., Banerjee, A., Carter, C. S., & Buford, T. W. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.629164 · Cited by 12
Alexander, T., Snowden, J. A., Burman, J., Chang, H., Papa, N. D., Farge, D., Lindsay, J. O., Malard, F., Muraro, P. A., Nitti, R., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.722436 · Cited by 12
Genetic risk score in multiple sclerosis is associated with unique gut microbiome
Elsayed, N. S., Valenzuela, R. K., Kitchner, T., Le, T. N., Mayer, J. G., Tang, Z.-Z., Bayanagari, V. R., Lu, Q., Aston, P., Anantharaman, K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43217-4 · Cited by 12
Pérez-Muñoz, M. E., Sugden, S., Harmsen, H. J. M., Hart, B. A. ‘., Laman, J. D., & Walter, J. (2021) · iScience · doi:10.1016/j.isci.2021.102709 · Cited by 12
Beebe, K. D., Sampey, B. P., Watkins, S. M., Milburn, M. V., & Eckhart, A. D. (2014) · Clinical and Translational Science · doi:10.1111/cts.12131 · Cited by 12
Environmental Factors and Their Impact on the Intestinal Microbiota: A Role for Human Disease?
Biedermann, L., & Rogler, G. (2012) · Digestive Diseases · doi:10.1159/000342590 · Cited by 12
Peipert, D., Montgomery, T. L., Toppen, L. C., Lee, M. F. J., Scarborough, M., & Krementsov, D. N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1655428 · Cited by 11
The link between gut microbiota and multiple sclerosis from the perspective of barrier function
Ren, J., Niu, Z., Wang, J., Guo, J., Hao, H.-J., Gao, F., Liu, R., & Wang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652796 · Cited by 13
Overview of the Gut Microbiome
Blackmer‐Raynolds, L., & Sampson, T. R. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771463 · Cited by 11
Applied physiology: gut microbiota and antimicrobial therapy
Suslov, A. V., Panas, A., Sinelnikov, M. Y., Maslennikov, R. V., Trishina, A. S., Zharikova, T. S., Zharova, N. V., Kalinin, D. V., Pontes‐Silva, A., & Zharikov, Y. O. (2024) · European Journal of Applied Physiology · doi:10.1007/s00421-024-05496-1 · Cited by 11
A One-Two Punch in the Gut May Trigger Multiple Sclerosis
Maghzi, A., & Weiner, H. L. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.016 · Cited by 11
Fischer, H. J., Witte, A., Walter, L., Gröne, H., van den Brandt, J., & Reichardt, H. M. (2016) · The FASEB Journal · doi:10.1096/fj.15-277384 · Cited by 11
RAGs and BUGS: An alliance for autoimmunity
Rigoni, R., Grassi, F., VILLA, A. M., & Cassani, B. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1228517 · Cited by 11
Mucosal biopsy shows immunologic changes of the colon in patients with early MS
Moser, A. M., Spindelboeck, W., Strohmaier, H. M., Enzinger, C., Gattringer, T., Fuchs, S., Fazekas, F., Gorkiewicz, G., Wurm, P., Högenauer, C., et al. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000362 · Cited by 11
Valburg, C., Sonti, A. N., Stern, J. N. H., Najjar, S., & Harel, A. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520923955 · Cited by 11
Traub, J., Husseini, L., & Weber, M. S. (2021) · Pharmaceuticals · doi:10.3390/ph14010037 · Cited by 11
Namakin, K., Moghaddam, M. H., Sadeghzadeh, S., Mehranpour, M., Vakili, K. G., Fathi, M., Golshan-Tafti, A., Bayat, A., Tajik, A. H., Eskandari, N., et al. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01187-6 · Cited by 11
Gokulan, K., Khare, S., Williams, K., & Foley, S. L. (2016) · DNA and Cell Biology · doi:10.1089/dna.2015.3142 · Cited by 11
Faber, H., Kurtoic, D., Krishnamoorthy, G., Weber, P. C., Pütz, B., Müller‐Myhsok, B., Weber, F., & Andlauer, T. F. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02165 · Cited by 12
Self-citationPeripheral tolerance to insulin is encoded by mimicry in the microbiomePreprint
García, A. R., Paterou, A., Lee, M., Slawinski, H., Wicker, L. S., Todd, J. A., & Pękalski, M. Ł. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.18.881433 · Cited by 11
Domínguez‐Mozo, M. I., López‐Mecández, D., Villar, L. M., Costa‐Frossard, L., Villarrubia, N., Aladro, Y., Pilo, B., Montalbán, X., Comabella, M., Peño, I. C., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52259 · Cited by 11
El-Taibany, A. A., Heydarian, P., Porada, D. A., Seeds, M. C., & Atala, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595276 · Cited by 11
Gut-derived metabolites drive Th17 cell pathogenicity in multiple sclerosis
Rebeaud, J., Vigne, S., Bressoud, V., Carre, R., Ruiz, F., Peter, B., Phillips, N. E., Siewert, L. K., Roloff, T. C., Egli, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116326 · Cited by 12
Gut-Microbiota-Brain Axis and Depression
Evrensel, A., & Ceylan, M. E. (2017) · Springer eBooks · doi:10.1007/978-981-10-6580-4_17 · Cited by 11
Microbiome Methods in Experimental Autoimmune Encephalomyelitis
Daberkow, D. P., Hoffman, K. R., Kohl, H. M., Long, T., Kirby, T. O., & Ochoa‐Repáraz, J. (2021) · Current Protocols · doi:10.1002/cpz1.314 · Cited by 10
Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection
Samara, A., Cantoni, C., Piccio, L. M., Cross, A. H., & Chahin, S. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104768 · Cited by 10
The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications
Khawar, M. M., Ijaz, S., Goyal, P., Kandambige, D., Sharifa, M., Maslamani, A. N. J., Kutabi, S. A., Saleh, I., Albshir, M. M., Almadhoun, M. K. I. K., et al. (2023) · Cureus · doi:10.7759/cureus.48655 · Cited by 11
Kawakami, N., & Wekerle, H. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00442 · Cited by 10
Self-citationKumar, A., Karamchandani, A., & Singh, S. (2024) · Neuroscience Informatics · doi:10.1016/j.neuri.2024.100175 · Cited by 15
Molecular mimicry in the etiology of autoimmune diseases
Lis-Kuberka, J., Jarząb, A., & Witkowska, D. (2012) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1003484 · Cited by 10
Multiple sclerosis: more pieces of the immunological puzzle
Gold, R., & Montalbán, X. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70268-x · Cited by 10
Mucosal tolerance therapy in humans: Past and future
Rezende, R. M., Cox, L. M., & Weiner, H. L. (2019) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12500 · Cited by 12
Polepole, P., Bartenslager, A. C., Liu, Y., Petro, T. M., Fernando, S. C., & Zhang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26188 · Cited by 10
Escribano, B. M., Muñoz-Jurado, A., Luque, E., Conde, C., Feijóo, M., LaTorre, M., Valdelvira, M. E., Buendía, P., Giraldo, A. I., Caballero‐Villarraso, J., et al. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666211207101113 · Cited by 10
Low dose fumaric acid esters are effective in a mouse model of spontaneous chronic encephalomyelitis
Demir, S., Heckers, S., Pedreiturria, X., Heß, D., Trampe, A.-K., Chan, A., & Gold, R. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.05.010 · Cited by 10
Prifti, E., & Zucker, J. (2015) · Springer eBooks · doi:10.1007/978-981-287-527-3_12 · Cited by 10
Wexler, A. G., Frielle, C., Berry, G., Budgeon, L. R., Baccon, J., Christensen, N. D., & Waldner, H. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.11.004 · Cited by 10
Senescence and Senescence-Related Disorders
Wang, Z. P., & Inuzuka, H. (2013) · InTech eBooks · doi:10.5772/56158 · Cited by 12
Ahmadi, S., Hasani, A., Khabbaz, A., Poortahmasebi, V., Hosseini, S., Yasdchi, M., Mehdizadehfar, E., Mousavi, Z. B., Hasani, R., Nabizadeh, E., et al. (2024) · Biogerontology · doi:10.1007/s10522-024-10136-4 · Cited by 9
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome
Kensiski, A., Gavzy, S. J., Wu, L., Mas, V. R., Ma, B., & Bromberg, J. S. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00178-24 · Cited by 11
Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?
Pellicano, C., Leodori, G., Innocenti, G. P., Gigante, A., & Rosato, E. (2019) · Nutrients · doi:10.3390/nu11112629 · Cited by 9
Sharma, R., Singh, P. K., Onteru, S. K., & Singh, D. (2021) · Reproductive Biology · doi:10.1016/j.repbio.2021.100509 · Cited by 9
Combination of Probiotics and Natural Compounds to Treat Multiple Sclerosis via Warburg Effect
Ravi, A. K., & Muthukrishnan, S. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.057 · Cited by 10
Martín-Hersog, F. A., Muñoz-Jurado, A., Escribano, B. M., Luque, E., Galván, A., LaTorre, M., Giraldo, A. I., Caballero‐Villarraso, J., Agüera, E., Santamarı́a, A., et al. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2161132 · Cited by 9
Hart, B. A. ‘., Laman, J. D., & Kap, Y. S. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1443075 · Cited by 9
Microbiome and Diseases: Neurological Disorders
Slingerland, A. E., & Stein‐Thoeringer, C. K. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_18 · Cited by 9
Gut inflammation in the pathogenesis of acquired aplastic anemia
Zhao, X.-C., Sun, X.-Y., Zhao, L., & Meng, F. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000772 · Cited by 9
Immune-microbiome interplay and its implications in neurodegenerative disorders
Uniyal, A., Tiwari, V., Rani, M., & Tiwari, V. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00807-3 · Cited by 9
Archer, D., Pérez-Muñoz, M. E., Tollenaar, S. L., Veniamin, S., Hotte, N., Cheng, C. C., Nieves, K., Oh, J., Morceli, L., Muncner, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115321 · Cited by 8
Self-citationEffects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation
Bittner, S., Ruck, T., Göbel, K., Henschel, C. M., Afzali, A. M., Göb, E., Müntefering, T., Kleinschnitz, C., Wiendl, H., & Meuth, S. G. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.03.009 · Cited by 8
Multiple Sklerose und Mikrobiota
Hohlfeld, R., & Wekerle, H. (2015) · Der Nervenarzt · doi:10.1007/s00115-014-4248-7 · Cited by 8
Self-citationGut microbiota in inflammatory bowel disease: a target for therapy not to be missed
LARUSSA, T., Abenavoli, L., FABIANO, G., MANCUSO, M. A., POLIMENI, N., DUMITRASCU, D. L., & Luzza, F. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02907-7 · Cited by 8
Centa, M., Weinstein, E. G., Clemente, J. C., Faith, J. J., Fiel, M. I., Lyallpuri, R., Herbin, O., & Alexandropoulos, K. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102808 · Cited by 8
Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics
Shahi, S. K., Yadav, M., Ghimire, S., & Mangalam, A. K. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.06.001 · Cited by 8
Martire, S., Montarolo, F., Spadaro, M., Perga, S., Sforza, M. L., Marozio, L., Frezet, F., Bruno, S., Chiabotto, G., Deregibus, M. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062875 · Cited by 8
Chen, Y., Lü, L., Wang, K., Liang, R., Qiao, Y., Feng, Z., Zhang, J., Bai, M., Chen, H., Zhao, J., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9496926 · Cited by 8
Neurological Manifestations and Psychiatric Disorders in the Course of Inflammatory Bowel Diseases
Głuch, P., Swiatek, A., Dudek, P., Fabisiak, A., & Talar‐Wojnarowska, R. (2022) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3965 · Cited by 8
Immunoregulation of multiple sclerosis by gut environmental factors
Croxford, J. L., & Miyake, S. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12252 · Cited by 8
The Intestine: where amazing things happen
Gagliani, N., Huber, S., & Flavell, R. A. (2011) · Cell Research · doi:10.1038/cr.2011.204 · Cited by 8
Arndt, A., Hoffacker, P., Zellmer, K., Goecer, O., Recks, M. S., & Küerten, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099794 · Cited by 8
Pechenyak, N. R. B. (2013) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.1000141 · Cited by 8
In vivo imaging in autoimmune diseases in the central nervous system
Kawakami, N. (2016) · Allergology International · doi:10.1016/j.alit.2016.02.001 · Cited by 9
Evonuk, K. S., Moseley, C. E., Doyle, R. E., Weaver, C. T., & DeSilva, T. M. (2016) · Journal of Visualized Experiments · doi:10.3791/54348 · Cited by 8
Balfe, Á., Lennon, G., Lavelle, A., Docherty, N. G., Coffey, J. C., Sheahan, K. D., Winter, D. C., & O’Connell, P. R. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s145224 · Cited by 8
Probiotic Applications in Autoimmune Diseases
de Oliveira, G. L. V. (2018) · InTech eBooks · doi:10.5772/intechopen.73064 · Cited by 8
Harriman, R., & Lewis, J. S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.045 · Cited by 9
Sepsis and multiple sclerosis: Causative links and outcomes
Miljković, D. M., Stanisavljević, S., Jensen, I. J., Griffith, T. S., & Badovinac, V. P. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.07.008 · Cited by 8
Can microbes combat neurodegeneration?
Blacher, E. (2021) · Science · doi:10.1126/science.abi9353 · Cited by 8
Re-emergence of neuroinfectiology
Baumgärtner, W., & Löscher, W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1535-3 · Cited by 8
ALS Untangled No. 21: Fecal transplants
The ALSUntangled Group (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.814981 · Cited by 7
Wang, C., Li, H., Wang, T., Li, X., 刘建伟, Deng, A., & Jiao, X. (2025) · International Ophthalmology · doi:10.1007/s10792-025-03921-8 · Cited by 7
Lymphocytes T Helper 17 in Multiple Sclerosis: Regulation by Intestinal Microbiota
Moreira, B. B. D. S., Franzoi, A. E. D. A., Gonçalves, M. V. M., Nascimento, O. J. M., & Peron, J. P. S. (2019) · Journal of Neurology and Experimental Neuroscience · doi:10.17756/jnen.2019-051 · Cited by 7
Microbiota-Immune System Interactions in Human Neurological Disorders
Huang, Q., Fang, Y., Liao, D., & Xia, J. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200726222138 · Cited by 7
Gut Microbiome as Potential Therapeutics in Multiple Sclerosis
Zhu, W., Dykstra, K., Zhang, L., & Xia, Z. (2021) · Current Treatment Options in Neurology · doi:10.1007/s11940-021-00693-1 · Cited by 7
Li, L., Li, C., Yao, D., Hao, Y., Zhao, C., Yan, Q., Liu, J.-T., Liu, S.-Y., Zhu, W.-P., Du, Y., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1013413 · Cited by 7
Mannion, J. M., Segal, B. M., McLoughlin, R. M., & Lalor, S. J. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.04.003 · Cited by 7
Lehikoinen, J., Strandin, T. M., Parantainen, J., Nurmi, K., Eklund, K. K., Rivera, F. J., Vaheri, A. I., & Tienari, P. J. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578432 · Cited by 7
Singh, S. D., Bharali, P., & Nagamani, S. (2024) · Molecular Diversity · doi:10.1007/s11030-024-11028-y · Cited by 7
A Neuroprimer: Principles of Central Nervous System Immunity
Owens, G. P. (2017) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2017.08.004 · Cited by 8
Şizofreni Etyolojisinde Mikrobiyotanın Rolü
Kartalcı, Ş. (2017) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.358105 · Cited by 7
El holobionte enfermo, el ejemplo de la esclerosis múltiple
Castillo-Álvarez, F., & Marzo-Sola, M. E. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2018.08.019 · Cited by 7
Sajedi, D., Shabani, R., & Elmieh, A. (2022) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2022.3104.1 · Cited by 7
Multiple sclerosis and the intestine: Chasing the microbial offender
Peters, A., Gerdes, L. A., & Wekerle, H. (2024) · Immunological Reviews · doi:10.1111/imr.13357 · Cited by 7
Self-citationTherapeutic Potential of the Human Gastrointestinal Microbiome
Borody, T. J., Peattie, D. A., & Campbell, J. (2013) · Drug Development Research · doi:10.1002/ddr.21093 · Cited by 7
B cells in MS: Why, where and how?
Pikor, N., & Gommerman, J. (2012) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2012.03.006 · Cited by 12
Role of Microbiota in Neurodegenerative Diseases
Sobol, C. V. (2018) · Russian Journal of Developmental Biology · doi:10.1134/s1062360418060061 · Cited by 7
Abdurasulova, I. N., Тарасова, Е. А., Ермоленко, Е. И., Eliseev, A. V., Matsulevich, A. V., Бисага, Г. Н., Skulyabin, D. I., Suvorov, A. N., & Клименко, В. М. (2015) · Medical academic journal · doi:10.17816/maj15355-67 · Cited by 7
Holistic Fitness: Microbiomes are Part of the Holobiont’s Fitness
ROSENBERG, E. B. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-65317-0_4 · Cited by 7
Impact of environmental factors on alloimmunity and transplant fate
Riella, L. V., Bagley, J., Iacomini, J., & Alegre, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90596 · Cited by 7
Abdurasulova, I. N., Тарасова, Е. А., Kudryavtsev, I. V., Negoreeva, I. G., Ilves, A. G., Серебрякова, М. К., Ермоленко, Е. И., Ивашкова, Е. В., Matsulevich, A. V., Tatarinov, A. E., et al. (2019) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2019-3-4-504-522 · Cited by 7
Alterations of the nasal and oral microbiota in multiple sclerosis
Li, S., Montini, F., Song, A., Willocq, V., Chan, E., Shamah, R., Weiner, M., Glanz, B. I., Weiner, H. L., & Cox, L. M. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105959 · Cited by 6
Metadata
- Authors
- Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G.
- Affiliations
- Max Planck Institute of Neurobiology (DE)
- Max Planck Society (DE)
- Corresponding author
- Wekerle, Hartmut
- Krishnamoorthy, Gurumoorthy
- Venue
- Nature
- Published
- 2011-10-26
- Volume
- 479
- Issue
- 7374
- Pages
- 538-541
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2037907937
- Cited by
- 1,251
- References
- 29
- Citations by year
- 2026: 34 · 2025: 45 · 2024: 74 · 2023: 78 · 2022: 107 · 2021: 101 · 2020: 100 · 2019: 93 · 2018: 110 · 2017: 105 · 2016: 113 · 2015: 87 · 2014: 74 · 2013: 72 · 2012: 47
- FWCI
- 44.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Division of Materials Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- commensal gut microbiota, myelin autoantigens, myelin oligodendrocyte glycoprotein, multiple sclerosis, experimental autoimmune encephalomyelitis, autoimmune demyelination, autoantibody-producing B cells, CD4+ T cells, diet and microbiome, relapsing-remitting multiple sclerosis
- MeSH terms
- Animals, Autoantigens, B-Lymphocytes, Brain, Cell Movement, Diet, Encephalomyelitis, Autoimmune, Experimental, Germ-Free Life, Lymph Nodes, Lymphocyte Activation, Myelin Proteins, Myelin Sheath, Stomach, T-Lymphocytes, Autoimmunity, Cytokines, Germinal Center, Adoptive Transfer, Multiple Sclerosis, Relapsing-Remitting, Mice, Metagenome, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review